Cargando…

Rifampicin resistance among notified pulmonary tuberculosis (PTB) cases in South-Southern Nigeria

BACKGROUND: Rifampicin resistant pulmonary tuberculosis (RR-PTB) remains a global health burden especially in low income countries and among HIV positive individuals. OBJECTIVE: This study seeks to measure the prevalence of RR-PTB among confirmed PTB cases in Delta State South-Southern, Nigeria and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ukwamedua, Henry, Omote, Victor, Etaghene, Johnson, Oseji, Matthew Ejike, Agwai, Imaria Celia, Agbroko, Harrison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639537/
https://www.ncbi.nlm.nih.gov/pubmed/31360790
http://dx.doi.org/10.1016/j.heliyon.2019.e02096
_version_ 1783436484347428864
author Ukwamedua, Henry
Omote, Victor
Etaghene, Johnson
Oseji, Matthew Ejike
Agwai, Imaria Celia
Agbroko, Harrison
author_facet Ukwamedua, Henry
Omote, Victor
Etaghene, Johnson
Oseji, Matthew Ejike
Agwai, Imaria Celia
Agbroko, Harrison
author_sort Ukwamedua, Henry
collection PubMed
description BACKGROUND: Rifampicin resistant pulmonary tuberculosis (RR-PTB) remains a global health burden especially in low income countries and among HIV positive individuals. OBJECTIVE: This study seeks to measure the prevalence of RR-PTB among confirmed PTB cases in Delta State South-Southern, Nigeria and to determine the correlation between various factors affecting the prevalence of RRTB among notified pulmonary TB cases. MATERIAL AND METHODS: The study is cross-sectional and retrospective in design and was carried out in Delta State, South-Southern Nigeria among participants with notified pulmonary TB cases. Gene Xpert registers for the selected facilities (Central Hospital Warri, Central Hospital Sapele and Federal Medical Center Asaba) for the year 2017 were retrieved, data extracted and analyzed. RESULT: Prevalence of RR-PTB was 7.3% (47/643). Majority (11.3% and 11.4%) of RR-PTB cases were among ages 0–20 and 61–80 years respectively. The male group and HIV negative participants gave rates of 9.1% and 7.8% respectively. Rates reported for location of residence revealed that Delta Central had a rate that doubled Delta South and tripled Delta North. CONCLUSION: Although our study figures are lower when compared to other reports for the study region, age grades 0–20 and 61–80 years, the male gender and residence in Delta Central were highlighted as independent variables that influence the distribution of RR-PTB. While a call for the sustenance and if possible augmentation of control and eradication efforts is of high essence, further studies aimed at identifying and understanding co-variables to the ones highlighted are recommended.
format Online
Article
Text
id pubmed-6639537
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-66395372019-07-29 Rifampicin resistance among notified pulmonary tuberculosis (PTB) cases in South-Southern Nigeria Ukwamedua, Henry Omote, Victor Etaghene, Johnson Oseji, Matthew Ejike Agwai, Imaria Celia Agbroko, Harrison Heliyon Article BACKGROUND: Rifampicin resistant pulmonary tuberculosis (RR-PTB) remains a global health burden especially in low income countries and among HIV positive individuals. OBJECTIVE: This study seeks to measure the prevalence of RR-PTB among confirmed PTB cases in Delta State South-Southern, Nigeria and to determine the correlation between various factors affecting the prevalence of RRTB among notified pulmonary TB cases. MATERIAL AND METHODS: The study is cross-sectional and retrospective in design and was carried out in Delta State, South-Southern Nigeria among participants with notified pulmonary TB cases. Gene Xpert registers for the selected facilities (Central Hospital Warri, Central Hospital Sapele and Federal Medical Center Asaba) for the year 2017 were retrieved, data extracted and analyzed. RESULT: Prevalence of RR-PTB was 7.3% (47/643). Majority (11.3% and 11.4%) of RR-PTB cases were among ages 0–20 and 61–80 years respectively. The male group and HIV negative participants gave rates of 9.1% and 7.8% respectively. Rates reported for location of residence revealed that Delta Central had a rate that doubled Delta South and tripled Delta North. CONCLUSION: Although our study figures are lower when compared to other reports for the study region, age grades 0–20 and 61–80 years, the male gender and residence in Delta Central were highlighted as independent variables that influence the distribution of RR-PTB. While a call for the sustenance and if possible augmentation of control and eradication efforts is of high essence, further studies aimed at identifying and understanding co-variables to the ones highlighted are recommended. Elsevier 2019-07-16 /pmc/articles/PMC6639537/ /pubmed/31360790 http://dx.doi.org/10.1016/j.heliyon.2019.e02096 Text en © 2019 The Authors. Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Ukwamedua, Henry
Omote, Victor
Etaghene, Johnson
Oseji, Matthew Ejike
Agwai, Imaria Celia
Agbroko, Harrison
Rifampicin resistance among notified pulmonary tuberculosis (PTB) cases in South-Southern Nigeria
title Rifampicin resistance among notified pulmonary tuberculosis (PTB) cases in South-Southern Nigeria
title_full Rifampicin resistance among notified pulmonary tuberculosis (PTB) cases in South-Southern Nigeria
title_fullStr Rifampicin resistance among notified pulmonary tuberculosis (PTB) cases in South-Southern Nigeria
title_full_unstemmed Rifampicin resistance among notified pulmonary tuberculosis (PTB) cases in South-Southern Nigeria
title_short Rifampicin resistance among notified pulmonary tuberculosis (PTB) cases in South-Southern Nigeria
title_sort rifampicin resistance among notified pulmonary tuberculosis (ptb) cases in south-southern nigeria
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639537/
https://www.ncbi.nlm.nih.gov/pubmed/31360790
http://dx.doi.org/10.1016/j.heliyon.2019.e02096
work_keys_str_mv AT ukwameduahenry rifampicinresistanceamongnotifiedpulmonarytuberculosisptbcasesinsouthsouthernnigeria
AT omotevictor rifampicinresistanceamongnotifiedpulmonarytuberculosisptbcasesinsouthsouthernnigeria
AT etaghenejohnson rifampicinresistanceamongnotifiedpulmonarytuberculosisptbcasesinsouthsouthernnigeria
AT osejimatthewejike rifampicinresistanceamongnotifiedpulmonarytuberculosisptbcasesinsouthsouthernnigeria
AT agwaiimariacelia rifampicinresistanceamongnotifiedpulmonarytuberculosisptbcasesinsouthsouthernnigeria
AT agbrokoharrison rifampicinresistanceamongnotifiedpulmonarytuberculosisptbcasesinsouthsouthernnigeria